$0.0080
+0.0015 (+23.08%)
At Close: Jun 03, 2026
Evofem Biosciences Inc Shares Close the Day 10.8% Higher - Daily Wrap
02:55am, Friday, 24'th Dec 2021 Kwhen Finance
Evofem Biosciences Inc (EVFM) shares closed today 10.8% higher than it did at the end of yesterday. The stock is currently down 82.8% year-to-date, down 82.9% over the past 12 months, and down 56.9% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $0.49 and as low as $0.36 this week.Shares closed 91.7% below its 52-week high and 27.3% above its 52-week low.Trading volume this week was 59.6% lower than the 10-day average and 39.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 656.7% The company's stock price performance over the past 12 months lags the peer average by 492.3%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Evofem Biosciences, Inc. (NASDAQ:EVFM) CEO Buys $51,300.00 in Stock
11:40am, Thursday, 23'rd Dec 2021 Transcript Daily
Evofem Biosciences, Inc. (NASDAQ:EVFM) CEO Saundra L. Pelletier acquired 135,000 shares of the business’s stock in a transaction that occurred on Monday, December 20th. The shares were bought at an average price of $0.38 per share, with a total value of $51,300.00. The transaction was disclosed in a document filed with the Securities & Exchange […]
38 Stocks Moving In Tuesday''s Mid-Day Session
05:26pm, Tuesday, 21'st Dec 2021 Benzinga
Gainers Reliance Global Group, Inc. (NASDAQ: RELI ) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI ) climbed 71.4% to $13.06 after gaining over 7% on Monday. Biofrontera recently announced the first subject has been enrolled in the Phase 2b study to evaluate the safety and efficacy of Ameluz in combination with the red-light lamp BF-RhodoLED for acne. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS ) jumped 36% to $3.4550 after the company reported pan-coronavirus monoclonal antibody cocktail that retains effectiveness against the omicron variant, other covid-19 variants, SARS, MERS, and the common cold human coronaviruses. Petros Pharmaceuticals, Inc. (NASDAQ: PTPI ) shares climbed 33.8% to $4.55. Evofem Biosciences, Inc. (NASDAQ: EVFM ) rose 24.1% to $0.46. The companys CEO Saundra L Pelletier bought 135,000 shares at an average price of $0.38 per share. Quantum-Si incorporated (NASDAQ: QSI ) gained 23.7% to $7.83. IsoPlexis Corporation (NASDAQ: ISO ) jumped 22.2% to $5.99.
Evofem Biosciences Inc. (NASDAQ: EVFM) Stock Buying Tips
02:00pm, Friday, 17'th Dec 2021 Stocks Register
Evofem Biosciences Inc. (NASDAQ:EVFM) shares, rose in value on Thursday, 12/16/21, with the stock price down by -1.84% to the previous days close as strong demand from buyers drove the stock to $0.37. Actively observing the price movement in the last trading, the stock closed the session at $0.38, falling within a range of $0.3705 Evofem Biosciences Inc. (NASDAQ: EVFM) Stock Buying Tips Read More »
You Should Look At The Stock Forecast For Evofem Biosciences Inc. (NASDAQ: EVFM).
02:00pm, Monday, 13'th Dec 2021 Marketing Sentinel
In the last trading session, 3.99 million shares of the Evofem Biosciences Inc. (NASDAQ:EVFM) were traded, and its beta was -0.16. Most recently the companys share price was $0.46, and it changed around -$0.02 or -5.12% from the last close, which brings the market valuation of the company to $79.66M. EVFM currently trades at a You Should Look At The Stock Forecast For Evofem Biosciences Inc. (NASDAQ: EVFM). Read More »
Is The Stock A Good Investment? Evofem Biosciences, Inc. (NASDAQ:EVFM), Gaotu Techedu Inc. (NYSE:GOTU)
12:06am, Monday, 13'th Dec 2021 Stock Equity
Evofem Biosciences, Inc. (NASDAQ:EVFM) with the stream of -5.12% also noticed, India Gaotu Techedu Inc. (NYSE:GOTU) encountered a rapid change of 1.20% in the last hour of Fridays trading session. The post Is The Stock A Good Investment? Evofem Biosciences, Inc. (NASDAQ:EVFM), Gaotu Techedu Inc. (NYSE:GOTU) appeared first on Stocks Equity .
Evofem Biosciences Stock (EVFM): Why The Price Increased Today
12:35pm, Thursday, 09'th Dec 2021
The stock price of Evofem Biosciences Inc (NASDAQ: EVFM) increased by over 6% during intraday trading today. This is why it happened.
Evofem Biosciences, Inc. (NASDAQ:EVFM) Expected to Post Quarterly Sales of $2.76 Million
01:36am, Thursday, 09'th Dec 2021 Transcript Daily
Wall Street brokerages expect Evofem Biosciences, Inc. (NASDAQ:EVFM) to announce $2.76 million in sales for the current quarter, according to Zacks. Three analysts have made estimates for Evofem Biosciences earnings, with the lowest sales estimate coming in at $2.59 million and the highest estimate coming in at $3.10 million. Evofem Biosciences reported sales of $170,000.00 []
Evofem Biosciences to Adjourn Special Meeting of Stockholders on December 8, 2021
11:30am, Wednesday, 08'th Dec 2021 Evofem Biosciences
-- Meeting to Reconvene on December 15, 2021 --
Brokerages Expect Evofem Biosciences, Inc. (NASDAQ:EVFM) to Post -$0.26 Earnings Per Share
03:12pm, Saturday, 04'th Dec 2021 Dakota Financial News
Analysts expect Evofem Biosciences, Inc. (NASDAQ:EVFM) to post earnings per share of ($0.26) for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Evofem Biosciences earnings, with the highest EPS estimate coming in at ($0.21) and the lowest estimate coming in at ($0.29). Evofem Biosciences posted earnings of ($0.50) per share []
Zacks: Analysts Expect Evofem Biosciences, Inc. (NASDAQ:EVFM) Will Announce Quarterly Sales of $2.76 Million
07:36am, Wednesday, 01'st Dec 2021 Dakota Financial News
Equities analysts expect Evofem Biosciences, Inc. (NASDAQ:EVFM) to report sales of $2.76 million for the current quarter, according to Zacks. Three analysts have issued estimates for Evofem Biosciences earnings, with the highest sales estimate coming in at $3.10 million and the lowest estimate coming in at $2.59 million. Evofem Biosciences posted sales of $170,000.00 in []
Evofem Biosciences Inc. (NASDAQ: EVFM) Has Been Trading Down. What Are The Prospects For The Future?
01:30pm, Tuesday, 30'th Nov 2021 Stocks Register
Evofem Biosciences Inc. (NASDAQ:EVFM) traded at $0.43 at close of the session on Monday, 11/29/21, made a downward move of -2.03% on its previous days price. Looking at the stock we see that its previous close was $0.44 and the beta (5Y monthly) reads -0.49 with the days price range being $0.43 $0.447. In Evofem Biosciences Inc. (NASDAQ: EVFM) Has Been Trading Down. What Are The Prospects For The Future? Read More »
Evofem Biosciences Announces Successful Type C Meeting with FDA for STI Prevention Product Candidate
01:00pm, Tuesday, 30'th Nov 2021 Evofem BiosciencesUndertaking Stock: Evofem Biosciences, Inc. (NASDAQ:EVFM), iFresh Inc. (NASDAQ:IFMK)
10:55am, Tuesday, 30'th Nov 2021 Stock Equity
Evofem Biosciences, Inc. (EVFM) with the stream of -2.03% also noticed, India iFresh Inc. (IFMK) encountered a rapid change of 180.37% in the last hour of Mondays trading session. Evofem The post Undertaking Stock: Evofem Biosciences, Inc. (NASDAQ:EVFM), iFresh Inc. (NASDAQ:IFMK) appeared first on Stocks Equity .
We Just Learned Something New About Evofem Biosciences Inc. (NASDAQ: EVFM) This Week With Its -16.05% Loss
09:00pm, Friday, 26'th Nov 2021 Marketing Sentinel
During the recent session, Evofem Biosciences Inc. (NASDAQ:EVFM)s traded shares were 0.66 million, with the beta value of the company hitting -0.27. At the last check today, the stocks price was $0.44, reflecting an intraday loss of -2.48% or -$0.01. The 52-week high for the EVFM share is $5.53, that puts it down -1156.82 from We Just Learned Something New About Evofem Biosciences Inc. (NASDAQ: EVFM) This Week With Its -16.05% Loss Read More »
Sign In
Buy EVFM